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"Oval" Cell Phenotype by Exposure to
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KAREN G. NELSON, PhD, and
JUDITH D. SMITH, BSc
A diploid population of cultured rat hepatic epithelial
cells that expresses the "oval" cell phenotype was exposed
briefly and repetitively to N-methyl-N'-nitro-N-nitroso-
guanidine (MNNG), and the effect on more than 20
phenotypic properties was evaluated during the neoplas-
tic transformation ofthe population. MNNG treatments
ofthis hepatic epithelial cell population resulted in a pro-
gressively increasing phenotypic alteration and hetero-
geneity including changes in specific activities ofseveral
cellular enzymes and expression of isozymes, synthetic
functions, and various in vitro growth properties.
Changes in phenotypic expression were clustered episod-
PRODUCTION of hepatocellular carcinoma in rats is
a prolonged process characterized by the reproducible
occurrence of discrete populations of liver cells that ex-
press altered phenotypic properties. 1-3 Included among
the populations of phenotypically altered cells that ap-
pear in the liver during chemically induced carcinogen-
esis are "oval" cells4 and foci and nodules of altered
hepatocytes. It has been hypothesized that one or more
of these new populations is the precursor to hepatocel-
lular carcinoma"5 and represents preneoplastically al-
tered cells progressing to cancer. Although this provoc-
ative hypothesis has stimulated many studies, it has not
been possible to establish unequivocally that any of
these altered populations are precursors of hepatocel-
lular cancer. A major handicap to the tracing of cell
lineages leading to hepatocellular carcinoma has been
the inability to analyze clonally the in vivo process. Al-
though various types of cells can be isolated from livers
of chemically treated rats,6-8 and some of these isolated
cells can be transplanted into recipient animals, where
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ically and were associated with major karyotypic
changes. The development ofincreasing phenotypic het-
erogeneity preceding and accompanying tumorigenic-
ity in cultured liver epithelial cells in vitro and the specific
phenotypes that occur resemble superficially the pattern
ofphenotypic changes that occur in hepatocytes during
chemical hepatocarcinogenesis in vivo. The results ofthis
study provide the basis for future investigations to fur-
ther elucidate the mechanistic and linkage relationship
between specific pretumorigenic and paratumorigenic
phenotypes and tumorigenicity. (Am J Pathol 1985,
118:306-315)
they grow to form lesions,"` a lesion cannot be
identified as a clone arising from a single transplanted
cell. Several hundred thousand to several million genet-
ically heterogeneous cells must be transplanted to yield
a graft of liver tissue, and this situation prevents a
clonally based tracing of the process of neoplastic
progression in the chemically treated rat liver in vivo.
It appears possible that the clonal analysis of the de-
velopment of liver cancer may be accomplished with
the use of cultured liver cells in vitro. Although mature
hepatocytes cannot yet be continuously propagated in
Supported by NIH Grant CA29323. Dr. Tsao is Centen-
nial Fellow of the Medical Research Council of Canada. Dr.
Nelson was supported by Postdoctoral Research Service
Award, ES07017.
Accepted for publication September 19, 1984.
Address reprint requests to J. W. Grisham, MD, Profes-
sor and Chair, Department of Pathology 228H, University
of North Carolina, Chapel Hill, NC 27514.
306
TRANSFORMATION OF LIVER EPITHELIAL CELLS 307
culture,"2 they now can be made to cycle one or more
times in culture'3"4 Further manipulations of culture
conditions may make it possible to maintain cycling
hepatocytes in vitro for long periods, to clone them,
and to establish clonal subpopulations. Although it is
not yet possible to perform this study with hepatocytes,
it is possible to use cultured "oval" cells for this pur-
pose.'5 We recently have reported the isolation in cul-
ture and characterization of a diploid epithelial cell line
(WB-F344) derived from normal rat liver that expresses
the phenotypic properties of "oval" cells, including the
synthesis of both albumin and alpha fetoprotein and
the expression of selected enzymes and isozymes.'6 In
this paper we report that the exposure of these cells in
culture to the directly active carcinogenic chemical N-
methyl-N'-nitro-N-nitrosoguanidine (MNNG) induces
them to express altered phenotypic properties and
karyotypic changes that resemble those that occur in
liver cells of carcinogen-treated rats in vivo prior to the
acquisition of tumorigenicity.I7" 8 Some of the tumors
that occur after back-transplantation of tumorigenic
cells into syngeneic hosts resemble hepatocellular car-
cinomas. This paper characterizes the development of
phenotypic alterations and tumorigenicity of WB-F344




Imemzo tissue culture medium was obtained from
Associated Biomedic Systems, Inc., and fetal bovine se-
rum was obtained from GIBCO. Sheep anti-rat a-feto-
protein antibody was obtained from Nordic Immuno-
logical Reagents. Goat anti-rat albumin antibody and
rabbit anti-human fibronectin antibodies were obtained
from Cappel Laboratories. The Vectastain ABC kit was
from Vector Laboratories. Unless stated, all other chem-
icals were obtained from Sigma Chemical Company.
Tissue Culture
WB-F344 is a propagable rat epithelial cell line iso-
lated in our laboratory from the liver of an adult male
Fischer-344 rat. The detailed growth, kinetics, and the
karyotypic, histochemical, immunocytochemical and
isozymic characteristics of this epithelial cell line have
been presented elsewhere.'6 Methods for assessments
and analyses of karyotype, cellular DNA content by
flow cytometry, histochemistry, immunocytochemistry,
and growth in low calcium medium or in soft agar were
identical to those previously described.'6"19
Exposure of Cell Populations to MNNG
WB cells were exposed to MNNG in a final concen-
tration of 5 Mg MNNG/ml culture medium. MNNG was
weighed and dissolved in reagent grade acetone. A
sufficient volume of MNNG solution in acetone was
added to complete culture medium to yield a final con-
centration of 5 Mg/ml. Medium containing MNNG was
left in contact with cells for 24 hours; because of
the short biologic half-life of this chemical, actual ex-
posure was limited to about 90 minutes.20 The concen-
tration of acetone in culture medium was always less
than 1%qo. Acetone vehicle controls (lI o acetone) in com-
plete culture medium were carried in parallel, as were
controls maintained in complete culture medium with-
out additives.
Cell populations were exposed to MNNG during log-
arithmic growth. Following each exposure, treated
populations were allowed to recover from MNNG-
induced toxicity and to reach confluence, following
which they were split as noted above. One dish was
retreated when it entered logarithmic growth, and other
dishes were used to generate populations for immedi-
ate phenotypic analysis and for freezing for future
studies.
Acetone vehicle and basal medium controls were pas-
saged at intervals that caused them to undergo approx-
imately the same number of population doublings as
did the MNNG-treated cultures. Control cultures were
evaluated for phenotypic properties in parallel to
MNNG-treated cultures.
Assessment of Phenotypic Properties
Selected phenotypic properties were assessed in popu-
lations of treated and control cultures after each ex-
posure to MNNG. Phenotypic analysis other than enzy-
matic studies usually occurred within 3-6 population
doublings following the last exposure to MNNG (and
in similarly passage control cultures).
Enzymatic Studies
Preparation of Enzyme Extracts
Frozen cell lines were thawed simultaneously and cul-
tured in parallel. Enzyme extracts were prepared rou-
tinely from cultures 1 to 2 days after they had reached
confluence. For each test sample, two plates of cells were
harvested by trypsinization and pooled, washed three
times with cold PBS, and suspended in 0.1-0.2 ml of
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0.1 M Tris-HCI buffer, pH 7.4, containing 1 mM EDTA
and 5 mM 2-mercaptoethanol. Cells were lysed by three
freeze-thaw cycles and centrifuged at 100,000g for 1
hour, and the supernatant was used for measurement
of the activities of soluble cytoplasmic enzymes
(NADH-diaphorase, aldolase, glucose-6-phosphate de-
hydrogenase, and pyruvate kinase). The pellet was
resuspended in iWo Triton X and incubated at 0-4 C
for 2-4 days. After centrifugation for 30 minutes at
10,000g, the supernatant was collected and used for
measuring the activities of y-glutamyl transpeptidase
and alkaline phosphatase.
For extraction of lactate dehydrogenase (LDH), cells
were lysed in distilled water for 30 minutes at room tem-
perature and subsequently reconstituted with an equal
volume of a solution containing 25 mM sucrose and
0.15 M NaCl. Freezing was not used because it may in-
activate the muscle form of LDH isoenzyme.2'
NADH-diaphorase was assayed by following the
reduction of 2,6-dichlorophenol indophenol (DCPIP)
spectroscopically at 600 nm.22 The reaction mixture was
composed of 1.4 ml of 0.2M Tris-HCI buffer, pH 8.5,
containing 0.05 ml of 2.4 mM DCPIP, 0.1 ml of 28.2
mM NADH, and 10,il of enzyme extract. The enzyme
reaction was optimal at pH 8.5, rather than at pH 7.5.23
Activity of the enzyme was calculated from the initial
rate of decrease in absorbance at 600 nm with the use
of a millimolar extinction coefficient of 18.2 (Sigma
Chemical Co. data sheet). One unit was defined as
micromoles of DCPIP reduced per minute at room tem-
perature (22 ± 1 C).
Pyruvate kinase was assayed according to the method
of Bucher and Pfleiderer.24 The reaction mixture con-
tained 50 mM Tris-HCI buffer, pH 7.5, 10 mM MgC12,
150 mM KCI, 0.25 mM NADH, 2 mM ADP, 1 unit/ml
lactate dehydrogenase, and 3 mM phosphoenolpyru-
vate. One unit is defined as oxidation of 1 mol NADH
per minute at 37 C.
Glucose-6-phosphate dehydrogenase (G6PD), aldo-
lase, y-glutamyl transpeptidase, and lactate dehydro-
genase were assayed with Sigma's enzyme assay kits nos.
345-UV, 752, 545, and 340-UV, respectively. One unit
of activity of each of these enzymes represents the utili-
zation of 1 umol of substrate or the formation of 1 umol
of product at 37 C.
Alkaline phosphatase was assayed according to the
method of Lowry et al.25 One unit measures the hydrol-
ysis of 1 umole of p-nitrophenol per minute at 37 C.
Protein was measured in cytoplasmic enzyme extracts
by the method of Bradford26 with the use of the Bio-
Rad protein assay kit (Bio-Rad Laboratories). For mem-
branous enzymes solubilized in 1% Triton X, the
method of Bramhall et al27 was used. Bovine serum al-
bumin was used as reference protein.
Methods for the separation of aldolase, hexokinase,
and lactate dehydrogenase isozymes have been described
previously."6 Electrophoresis of phosphofructokinase
was carried out in glycyl-glycine buffer according to
Kemp. 28
Analysis of Tumorigenicity
Cultured cells were dispersed by 0.250Wo trypsin in
Ca2+-Mg2+-free Hanks' solution and then washed twice
in Hanks' salt solution. One million cells in 0.1 ml were
inoculated subcutaneously into the abdominal wall of
each of several 1-day-old Fischer 344 rats of both sexes.
Tumor-bearing rats were killed when neoplasms were
about 1-2 cm in diameter. Rats in which tumors could
not be palpated were killed 16 months after inocula-
tion of cells. Tissues at the site of inoculation (includ-
ing obvious tumors) were examined histologically.
Results
From the parental population of WB hepatic epithe-
lial cells, we have developed 33 sublines, based on the
number of repeated exposures to MNNG or to acetone
vehicle and on the number of population doublings.
Sublines WB-5-1 to WB-5-11 were exposed to 5 ,ig
MNNG/ml of culture medium 1-11 times. Control sub-
lines WB-A-1 to WB-A-11 were exposed to basal cul-
ture medium containing acetone vehicle (less than 1Wo
acetone). Sublines WB-0-1 to WB-0-11 were doubling
controls which were subcultured in basal medium at ap-
propriate intervals so that they went through the same
number of transfers and approximately the same num-
ber of population doublings as did the MNNG-treated
populations. No significant differences in the parameters
studied were discerned between WB-A and WB-0 sub-
populations. In addition, we have studied a cell line
(WB-5-11-T) reestablished in culture from one of the
tumors produced by subcutaneously inoculating a day-
old Fischer-344 rat with 106 WB-5-11 cells.
Growth Characteristics
Cell populations treated with MNNG demonstrated
a decrease in doubling time, which paralleled that of
the multiply subcultured WB-0 and WB-A cells. In sim-
ilar fashion, colony formation increased progressively
with repetitive subcultures or treatments with MNNG,
and values between the two did not differ significantly
(Figure 1). The saturation density did not change
significantly in populations of either control or MNNG-
treated cells during approximately 35 population doub-
lings and 11 consecutive treatments with MNNG.
Cell populations treated repetitively with MNNG
(WB-5) showed improved growth in calcium-deficient
AJP * February 1985





0>4 - 4 5 6 7
PASSAGES/TREATMENTS
Figure 1-Colony-forming efficiency of control WB cells (black bars) and
of Wb cells treated up to 10 times with 5 pg MNNG/ml as described in
the text (open bars). Mean colony-forming efficiencies did not differ signifi-
cantly (mean ± SD).
medium after 6-8 treatments, and the population
treated 11 times withMNNG (WB-5-11) grew in calcium-
poor medium (0.02 mM) with 55%o to 850% of the
efficiency as in calcium-rich (2.0 mM) medium. Con-
trol populations (WB-0 and WB-A) demonstrated no
significant improvement in their ability to grow in
calcium-poor medium. The tumor-derived line (WB-
5-11-T) grew equally well in medium containing either
high or low levels of calcium.
As were the WB-0 and WB-A cells, MNNG-treated
populations were unable to form colonies in soft agar
prior to treatment 11 (WB-5-1l), when a few tiny colo-
nies estimated to contain fewer than 50 cells were seen.
In contrast, the tumor-derived line (WB-5-11-T) formed
progressively enlarging colonies in soft agar with rela-
tively high efficiency (>10%o).
Tumorigenicity
When tested within five population doublings after
treatment with MNNG, only the population of cells
treated 11 times with MNNG (WB-5-11) was tumori-
Table 1 -Chromosomal Characteristics of WB Cells Treated
Multiply With MNNG
Euploid Aneuploid
Cell line (Diploid and tetraploid) Paradiploid Paratetraploid
WB-0-0 94% ± 5% 6% + 5% 0
WB-5-1 61 36 5
WB-5-2 63 24 13
WB-5-3 60 25 15
WB-5-4 66 22 16
WB-5-5 42 15 43
WB-5-7 50 16 44
WB-5-9 48 15 45
WB-5-10 28 18 54
WB-5-11 18 33 59
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Figure 2-Flow cytofluorometric tracing of DNA/cell in populations of WB
cells treated 11 times with 5 pg MNNG/ml (B) and a control population
passaged for a similar number of population doublings in culture (A). Also
shown is the tracing from a population of cells (WB-5-1 1-T) reestablished
in culture from a tumor formed from WB-5-11 cells (C). MNNG treatment
appears to cause the development of a subtetraploid clone in the WB-5-1 1
population (which is lacking in the controls). Cells in the tumor produced
by WB-5-1 1 cells are all subtetraploid (WB-5-1 1-T), indicating that the sub-
tetraploid clone was able to grow selectively in vivo.
genic. When 106 cells of this population were inocu-
lated subcutaneously into each of 61 1-day-old Fischer-
344 rats, in 21 (34%) progressively enlarging tumors de-
veloped during the next 16 months. The latent period
before the appearance of the first tumor was 10 months.
Neoplasms were poorly differentiated tumors resem-
bling hepatoblastomas, hepatocellular carcinomas, or
biliary adenocarcinomas. Control populations (WB-0-
X K .... ..
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Figure 3-Electrophoretic patterns of aldolase isozymes. Panels contained
extracts from the following tissues and culture populations: I, fetal rat liver;
II, WB-O cells; Ill, rat brain; IV, WB-5-2 cells; V, WB-5-5 cells; VI, WB-5-6
cells; VIl, WB-5-7 cells; VIII, WB-5-1 1 cells; IX, WB-5-1 1-T cells. The letters
A, B, and C refer to designated isozymes, which form as multimers. Mul-
timers A3C, A2C2, AC3, and C4 can be seen in brain, WB-5-0, WB-5-2, and
WB-5-5 populations show weak A3C bands, which are lacking in more ex-
tensively treated populations.
11 and WB-A-11) subcultured for equivalent population
doublings in vitro were not tumorigenic even when 10'
cells were transplanted into 1-day-old Fischer-344 rats.
DNA Cytofluorometry and Karyotypic Analysis
WB-0 cells were karyotypically diploid. By DNA
cytofluorometry both the diploid (G1) and tetraploid
(G2) peaks demonstrated slight but perceptible widen-
ing during multiple treatments with MNNG. Karyotypic
analyses of the same populations indicated that widen-
ing of diploid and tetraploid peaks resulted from in-
creased proportions of cells that contained hypodiploid
and hyperdiploid and hypotetraploid and hyper-
tetraploid numbers of chromosomes (Table 1). Data in
Table 1 also indicate that major aneuploid shifts oc-
curred after treatments 1, 2, 5, and 11. In the popula-
tion of cells treated 11 times with MNNG (WB-5-11),
DNA cytofluorometry showed a distinct hypotetraploid
peak (Figure 2), which was corroborated by karyotypic
analysis of the same population. That the hypotetra-
ploid cells of the WB-5-11 population were responsible
for tumor formation is suggested by the finding that
the WB-5-11-T population, derived from a tumor pro-
duced in vivo by transplantation of WB-5-11 cells, was
composed totally of subtetraploid cells.
TREATMENTS
Figure 4-Specific activity of alkaline phosphatase in WB cells multiply
treated with MNNG. T indicates cells of the tumor-derived line (WB-5-1 1 -T).
Vertical bars indicate standard deviation.
Nonenzymatic Cellular Products
As did the WB-0 and WB-A cells, all MNNG-treated
populations continued to be positive for both albumin
and a-fetoprotein. Cells derived from a tumor (WB-5-
11-T) contained neither albumin nor a-fetoprotein. In
contrast, multiply treated populations (WB-5-7 to WB-
5-11) developed the capacity to store putative glycogen
(PAS-positive, diastase-resistant material), and cells of
the tumor-derived line (WB-5-11-T) contained large
amounts of putative glycogen.
Expression of intracellular cytokeratin fibers was
maintained in WB cells after multiple treatments with
MNNG, as well as in the tumor-derived population.
Fibronectin continued to be found extracellularly in
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TREATMENTS
Figure 5-Activity of glucose-6-phosphate dehydrogenase in WB cells
multiply treated with MNNG. T indicates cells of the tumor-derived line
(WB-5-1 1 -T). Vertical bars indicate standard deviations.
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TREATMENTS
Figure 8-Activity of pyruvate kinase in WB cells multiply treated with
MNNG. T indicates cells of the tumor-derived line (WB-5-1 1-T). Vertical bars
indicate standard deviations.
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TREATMENTS
Figure 6-Activity of LDH in WB cells multiply treated with MNNG. T indi-
cates cells of the tumor-derived line (WB-5-1 1-T). Vertical bars indicate
standard deviations.
populations extracellular fibronectin was focally
deficient. Foci of cells in the population treated 11 times
with MNNG (WB-5-11) lacked extracellular fibronec-
tin. Cells of the tumor-derived line (WB-5-11-T) failed
to produce extracellular fibronectin.
Enzymes and Isozymes
No significant alterations in enzyme activities were
noted in control populations (WB-0 and WB-A) dur-
I I II
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Figure 7-Activity of NADH-diaphorase in WB cells multiply treated with
MNNG. T indicates cells of the tumor-derived line (WB-5-1 1 -T). Vertical bars
indicate standard deviations.
ing approximately 20 subcultures. Of the enzymes stud-
ied, aldolase was the only one whose activity was not
affected by treatment with MNNG. However, modest
changes did occur in the expression of aldolase iso-
zymes. The expression of A and A3C isozymes was
maintained in control cultures and in MNNG-treated
cultures through six consecutive treatments, after which
the type C isozyme was lost (Figure 3). The type B iso-
zyme, characteristic of adult liver,29 was never seen.
Alkaline phosphatase decreased markedly in activity
after only two or three treatments, reaching a nadir by
six treatments and remaining low for the rest of the
study period (Figure 4).
Glucose-6-phosphate dehydrogenase (Figure 5), lac-
tate dehydrogenase, (Figure 6), NADH-diaphorase (Fig-
ure 7), and pyruvate kinase (Figure 8) all increased in
specific activity and/or showed modified isozyme pat-
terns in populations of treated cells between Treatments
5 and 7. The results of the study of hexokinase isozymes
are shown in Table 2. WB cells expressed only the Type
I and II isozymes, Type I being the predominant form.
Populations of WB cells treated more than six times
with MNNG showed an increased fraction of Type II
isozyme. In addition, WB-5-11-T cells expressed a small
but inconstant amount of Type III isozyme. Type IV
isozyme was never expressed. The distribution of lac-
tate dehydrogenase isozymes in WB cells is shown in
Table 3. After two treatments with MNNG, populations
of cells showed sharply increased fractions of the M4
isozyme. In populations ofWB cells treated more than
6 times with MNNG, phosphofructokinase showed an
extra, slower-moving band, in addition to the two bands
found in all control cell populations (Figure 9).
The specific activity of y-glutamyl transpeptidase re-
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tion of Hexokinase Isoenzymes in Rat Tissues typic expression in a population of cultured diploid
ielial Cells in Culture hepatic epithelial cells that express the "oval" cell pheno-
Percent of total hexokinase activity type. Phenotypic alterations emerge in a pattern which
Hi Hil Hill Hiv(G) appears to be related to the number of treatments with
820/0 18% 00/0 00/0 MNNG and can be categorized into early (expressed
83%0 17% 00 00/a by the fourth treatment), intermediate (expressed be-
74% 26% 0% 0% tween the fifth and eighth treatments), and late (ex-
79% 21% 0% 0% pressed after the ninth treatment) stages (Table 4). These
75% 25% 0% 0%
71% 29% 0% 0% clusters of phenotypic changes are temporally correlated
51% 49% 0% 0% with major changes in karyotype, and the pattern resem-
62% 38% 0% 0% bles that occurring in the focally altered hepatocytes
71% 29% 0% 0%0/
60% 40% 0% 0% of rats undergoing chemicallyinduced carcinogenesis
73% 27% 0% 0% in vivo.1
44% 530/a 3% 00/a Chemical hepatocarcinogenesis in rats is a multistep
glucokinase. Values are averages of two to four process characterized by the sequential emergence of
altered islands, foci, neoplastic nodules, and carci-
nomas. Early lesions such as islands, foci, and nodules
11 consecutive treatments (Figure 10). are characterized by altered enzyme histochemical stain-
umor-derived cell line (WB-5-11-T) ex- ing properties, such as diminished activity (negative
ly increased activity of this enzyme (Fig- markers) of glucose-6-phosphatase and ATPase or en-
ta-glutamyl transpeptidase was not ex- hanced activity (positive markers) of GGT, DT-dia-
emically in parental or multiply passaged phorase, G6PD, glyceraldehyde-3-phosphate dehydro-
-0 and WB-A) when the reaction time genase and epoxide hydrolase.18 19 Elevation of specific
and only faintly when the reaction time activities of pyruvate kinase in hyperplastic nodules also
o 30 minutes. Under these same condi- has been reported.30'31 This study suggests that the en-
treated populations (WB-5) also showed zymatic alterations produced during in vivo studies of
tl weakly positive cells. However, after rat hepatocarcinogenesis can be reproduced in vitro by
treatments (WB-5-11), a few cells were treatment of rat liver epithelial cells with MNNG.
ed intensely for y-glutamyl transpepti- Elevated specific activities of NADH-diaphorase,
n a 5-minute reaction. Histochemical G6PD, pyruvate kinase, and GGT preceded or accom-
)nies arising from single cells indicated panied the emergence of tumorigenicity after multiple
,of the cells in the WB-5-11 population carcinogen treatments. These phenotypic changes were
iically positive for y-glutamyl transpep- seen in populations of cells which received more than
Le reaction time). In contrast, over 7507o six carcinogen exposures, whereas the specific activity
e positive in the WB-5-11-T line derived of alkaline phosphatase was depressed after only one
iroduced from the WB-5-11 population. to two treatments. The latter enzyme is a sensitive
marker of the action ofMNNG on this rat liver epithe-
Discussion lial cell line.
Specific activity of LDH in hyperplastic nodules of
lemonstrates that repeated brief treat- rat livers during carcinogenesis has not been reported,
ING induce progressively altered pheno- but elevation in LDH activity concomitant with an in-
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Figure 9-Electrophoretic patterns of phosphofructokinase isozymes.
Panels contained extracts from the following tissues and culture popula-
tions: A, rat skeletal muscle; B, rat adult liver; C, rat fetal liver; D, WB-0
cells; E, WB-5-1 cells; F, WB-5-6 cells. Two bands, which are distinct from
the muscle band, are seen in rat liver. WB cells show the liver bands. Six
treatments with MNNG cause the appearance of a muscle band in WB
cells.
crease in "muscle"-type LDH isozyme expression in rat
and human hepatocellular carcinoma as well as tumors
of other human organs have been documented am-
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Figure 10-Activity of y-glutamyl transpeptidase in WB cells multiply
treated with MNNG. Tindicates cells of the tumor-derived line (WB-5-1 1-T).
When reacted for 5 minutes, no histochemically GGT-positive cells could
be discerned in WB populations prior to WB-5-1 1. The latter population
contained 9% + 1% cells that reacted strongly for GGT histochemically.
More than 750/0 of the cells of the tumor-derived line (WB-5-1 1-T) were his-
tochemically strongly positive for GGT. Vertical bars indicate standard
deviations.
Table 4-Summary of Phenotypic Changes in Populations of
WB Cells Treated Multiply With MNNG
MNNG
Chronology treatments Phenotype
Early 1-3 Paradiploid aneuploidy
Decreased alkaline phosphatase






Increased hexokinase isozyme 2
Loss of aldolase isozyme C
Appearance of new phosphofruc-
tokinase isozyme
Late 9-11 Hypotetraploid aneuploidy
GGT-positive cells
Increased LDH isozyme 5
Glycogen storage in some cells
Focally absent extracellular
fibronectin
Ability to grow in Ca2+-poor medium
Ability to grow in soft agar
Tumorigenic in isogeneic rats
specific activity of aldolase was not changed by multi-
ple carcinogen treatments. Aldolase specific activity also
is generally not significantly elevated in malignant
tumors,34 possibly because it is not a key regulatory en-
zyme in the metabolic pathway.
In addition to the biochemical or enzymatic changes,
rat liver epithelial cells also developed an aneuploid sub-
population of cells following multiple carcinogen treat-
ments. This change also has been documented in
hepatocytes initiated in rat livers during chemical car-
cinogenesis.35 The development of aneuploidy may con-
stitute a critical step in neoplastic transformation.36
Multiple exposures of cells to carcinogen induced in-
creasing phenotypic alterations, and the final tumori-
genic population produced following 11 treatments with
MNNG demonstrated the most marked changes in the
phenotypes. The enzymatic and isozymatic changes ob-
served were not the result of multiple subcultures only,
because enzymatic assays were made repeatedly dur-
ing 11 or more passages of control cultures (WB-0 and
WB-A) and systematic alterations of activities were not
observed. It is also unlikely that the enzyme changes
observed represent the result of selection of cells by car-
cinogen treatments, because the treatments were briefly
episodic rather than prolonged.
Neoplastic lesions in rat livers have been induced by
single carcinogen treatment or continuous carcinogen
exposure in the diet.37 Mechanistic studies of carcino-
genesis and neoplastic progression can be performed
only in a system involving initiation by a single carcino-
gen treatment, because continuous or multiple treat-
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ments by carcinogen may result in multiple and ran-
dom episodes of genomic damage and thereby make
studies to trace sequential progression impossible.38 Pre-
viously reported studies of carcinogenic transformation
in rat liver epithelial cells in culture have been performed
only by multiple or continuous carcinogen treat-
ments,39 43 because neoplastic transformation after a
single in vitro treatment with a chemical carcinogen has
not been accomplished. Nevertheless, it is possible to
trace the connection between specific phenotypes and
tumorigenicity by evaluating the clonal segregation of
tumorigenicity and the chosen phenotype. Using this
strategy, we already have shown that the ability of cells
to grow in Ca2l-poor medium, a putatively neoplastic
phenotypic property, does not segregate with tumorige-
nicity. 19
The in vivo and in vitro studies differ significantly
in one important aspect. Cells in foci or neoplastic nod-
ules or chemically treated rat livers are morphologically
similar to hepatocytes and may be derived from preex-
isting hepatocytes. Rat liver epithelial cells in culture
are phenotypically very similar to the "oval" or bile duc-
tular cells. It should be noted that some investigators
posit that chemically induced hepatocellular carci-
nomas in rats may be derived from "oval" cells.5 In any
event, the results reported here are useful because they
demonstrate a phenotypic parallelism between the in
vivo and in vitro studies. Studies with cell culture sys-
tems can complement the in vivo mechanistic studies
of rat hepatocarcinogenesis because of the relative ease
with which cultured cells can be manipulated and with
which clonal subpopulations that express a specific
phenotypic expression can be selected. Such clonal
studies are important in establishing firmly whether
phenotypic changes observed during neoplastic or tu-
mor progression are mechanistically or sequentially
linked to the induction of tumorigenic phenotype.
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